ATG7 and metabolic dysfunction-associated steatotic liver disease: A recent whole-exome sequencing study in individuals with non-alcoholic fatty liver disease (NAFLD) or HCC identified ATG7 loss-of-function variants that impair autophagy and promote p62 accumulation, ballooning, and inflammation (Baselli et al, 2022).